UPDATE: Citigroup Downgrades Masimo Corporation to Sell
Citigroup lowers its rating on Masimo Corporation (NASDAQ: MASI) to Sell from Neutral and lowers its price target to $20 from $21 on utilization challenges.
Citigroup says, "2012 is unlikely to get easier for MASI after a tough 2011 where we saw further margin erosion and limited technology adoption among hospital customers. Software updates and the Pronto-7 re-launch also won't fix larger headwinds tied to reprocessed sensors and difficult admission trends for the core pulse-oximetry business."
MASI closed at $21.81 a share on Thursday.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.